Summary
74 / 100 · Bulios Score
What speaks for it
- Out of every 100 ZAR of revenue, 31 ZAR is left as net profit.
- Earnings per share grew by 17% a year over the last 3 years.
- Analysts expect revenue to grow by 14% this fiscal year.
What to watch
- The share price is above the Bulios Fair Price.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 37.9 ZAR for 1 ZAR of yearly profit.
Valuation in detailIs it growing?
Yes, fastRevenue (ZAR)
Diluted EPS (ZAR)
- Analyst estimate
Revenue grew by 85% a year over 5 years. Over the last 3 years it grew by 164% a year. For the next fiscal year analysts expect revenue to grow by 14%. Earnings per share grew by 17% a year over the last 3 years.
Growth in detailDoes it make money?
Income figures for the last 12 months are not available.
Profitability in detailIs it financially healthy?
Banks and insurers work with their customers' money, so their debt is judged differently; see the health section for their capital figures.
Financial health in detailDoes it pay a dividend?
Small, stretched- Yield
- 1.87%
- Paid out of profit
- 71%
- Raised in a row
- 3 years
You receive $2.55 per share a year. The payout takes a large part of its profit or free cash flow.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.